Dyclonine is an oral anaesthetic that is the active ingredient of Sucrets, an over-the-counter throat lozenge. It is also found in some varieties of the Cepacol sore throat spray. It is a local anesthetic, used topically as the hydrochloride salt. In technical terms dyclonine hydrochloride is formulated to provide rapid onset topical analgesia by reversible inhibition of peripheral nerve conduction; it preferentially blocks voltage gated sodium channels at sensory nerve endings in the oropharyngeal mucosa. The hydrochloride salt form improves aqueous solubility and formulation stability, making it suitable for lozenges, sprays and topical solutions. Typical manufacturing and formulation workflows employ purified dyclonine hydrochloride characterized by HPLC purity, melting point confirmation and identity by IR or NMR. Standard excipients for throat products include humectants, flavoring agents and buffering salts to maintain efficacy and palatability while minimizing mucosal irritation. Quality control emphasizes particle size distribution, microbial limits and residual solvent profiling to ensure batch to batch consistency for topical use.
Typical pharmaceutical specifications for dyclonine hydrochloride target high assay and tight control of related substances; a representative specification used by manufacturers sets an assay not less than 98.0 percent on a dried basis, individual related impurities controlled to 0.5 percent or less and total related impurities not to exceed 1.5 percent. Common related compounds observed in stability and process profiles include N dealkylation products, minor oxidation products such as N oxides, ether cleavage fragments from the alkoxy side chain and trace coupling or rearrangement by products from synthesis. Analytical control is usually performed by stability indicating reversed phase HPLC for related substances, GC for residual solvents and ICP or AAS for elemental impurities with limits for heavy metals typically in the low ppm range. Impurity limits and identification thresholds follow ICH principles with reporting and identification at specified thresholds dependent on maximum daily exposure from the finished product.
Dyclonine is used as a topical oral anaesthetic to relieve pain or irritation of the throat and oral mucosa; it is formulated into lozenges, sprays and topical solutions to provide localized numbing for symptomatic relief during sore throat, minor procedures or mucosal irritation.
When used as directed in topical OTC preparations dyclonine is generally considered safe; adverse effects are usually local and may include transient numbness, mild irritation or hypersensitivity reactions. Systemic toxicity is uncommon at labeled doses but overuse or inappropriate application can increase risk. Product labeling and professional guidance should be followed for children, pregnant or lactating patients and individuals with known sensitivity to local anesthetics.
Onset of topical dyclonine is typically within a few minutes after application, with clinically useful anaesthesia generally lasting from about 30 minutes up to 60 minutes depending on formulation, dose and local conditions; duration can vary between lozenges and sprays.
A well known brand containing dyclonine is Sucrets; dyclonine is also an ingredient in some versions of the Cepacol sore throat spray.
